Virus-specific early antigen expressed in the nucleus of cowpox virusinfected cells N. Kitamoto,*t K. Hiroi, K. Miyamoto, T. Tanaka and H. Miyamoto Department of Microbiology, Wakayama Medical College, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Japan Two monoclonal antibodies (MAbs) were obtained from BALB/c mice immunized with cowpox virus (CPV)-infected cells cultured in the presence of cytosine-l-fl-D-arabinofuranosyl-HCl (Ara C). In the immunofluorescence test, the specific antigen reacting with these MAbs was restricted almost entirely to the nucleus in CPV-infected cells in the presence of Ara C at any time. On the other hand, in CPV-infected cells in the absence of Ara C, the antigen was first detectable within the nucleus 2 h after infection and migrated to the cytoplasm as the infection proceeded. On immunoblotting, only one component with an Mr of 27K was detected 2 to 24 h after infection of cells with CPV in either the presence or absence of Ara C. The antigen was also detected in vaccinia virus-infected cells, but not in any mock-infected cells nor in any virions purified from infected cells. These results suggest that the antigen reacting with the MAbs is virus-specific and a non-structural early antigen.
A number of enzymes encoded by poxvirus genomes have been reported and most of these enzymes have been shown to be associated with early genes and are packaged within the mature virions (for reviews, see Dales & Pogo, 1981 ; Moss, 1974) . Also it has been known for some time that the major site of poxvirus RNA and DNA synthesis is in cytoplasmic factories (or virosomes) in infected cells (Becker & Joklik, 1964; Cairns, 1960; McAuslan, 1969; Nevins & Joklik, 1977) . However it has been reported more recently that in addition to viral DNA (Archard, 1983; LaColla & Weissbach, 1975) and RNA (Bolden et al., 1979; Gafford & Randall, 1976) synthesis, viral DNA-dependent RNA polymerase (Wing & Weissbach, 1984; Morrison et al., 1985) and cellular RNA polymerase (Bloom et al., 1989; Wilton & Dales, 1989) activities occur within the nucleus of infected cells. In addition it has been shown that the nucleus carries out an unknown but essential role during poxvirus replication (LaColla & Weissbach, 1975; Prescott et al., 1971) and that a functional nucleus is required for productive infection (Moyer, 1987) . Therefore it is of particular interest to examine the role of the nucleus in poxvirus replication and to determine the localization of these enzymes in the nucleus and/or cytoplasm of infected cells. The availability of a monoclonal antibody (MAb) would facilitate a number 0000-9061 © 1990 SGM of these studies, but no MAb directed against the virusspecific early antigens associated with the nucleus of poxvirus-infected cells has yet been obtained. In this work we produced MAbs recognizing a certain antigen expressed in the nucleus of cowpox virus (CPV)-infected cells and used them to study the kinetics of biosynthesis and the polypeptides of the antigen.
RK13 cells derived from rabbit kidney cells, HeLa cells derived from a human carcinoma and L cells derived from mouse fibroblasts were grown in MEM supplemented with 3 ~ calf serum. Primary kidney cells derived from a BALB/c mouse (BK cells) were propagated in Dulbecco's modified Eagle's medium supplemented with 10~ foetal calf serum. The strain of CPV used was LB red; vaccinia virus (VV) strains were WR, Ikeda, Lister, IHD-W, IHD-J and Dis, and the Shope fibroma virus (SFV) strain was OA. Each virus was propagated in RK13 cells in the logarithmic phase of growth and purified according to Joklik (1962) . Virions were centrifuged through a 36 ~ sucrose cushion (partially purified virions), banded once in linear sucrose gradients (25 to 36~o), and re-centrifuged through a sucrose cushion (purified virions). BALB/c mice were immunized with CPV (LB red strain)-infected BK cells cultured for 5 h in the presence of cytosine-l-fl-oarabinofuranosyl-HCl (Ara C, 50 ktg/ml). Mice were primed intraperitoneally (i.p.) with CPV-infected BK cells emulsified in Freund's complete adjuvant, and were boosted twice, with a 2 week interval. After 2 weeks, the animals received a final injection i.p. of CPV-infected Short communication BK cells without adjuvant. Three days later, the animals were sacrificed for fusion experiments. The methods for production and culture of hybridomas and the screening procedures for antibodies have been described previously ( Kitamoto et al., 1984) . Hybridomas were obtained from cultures of myeloma cells (P3-X63-Ag8U1) fused with spleen cells from immunized mice. MAbs were used in the form of ascites fluid obtained as described previously (Kitamoto et al., 1986) . The indirect immunofluorescence (IF) test used for the screening and characterization of antibodies was carried out with cells infected with each virus at an m.o.i, of 10, cultured in the presence or absence of Ara C (50 ~tg/ml) for appropriate periods after infection and then fixed with cold acetone for 10 min. For the membrane IF (MIF) test, cells infected (m.o.i. of 10) and cultured for appropriate times were used without fixation. The techniques fo~ immunoblotting (Western blotting) with MAbs by the method of Towbin et al. (1979) with slight modification have been described in detail elsewhere (Kitamoto et al., 1986) . Mock-infected and infected (appropriate times after infection; m.o.i, of 10) cells cultured in the presence or absence of Ara C were solubilized in sample buffer (3 ~o SDS, 3~ 2-mercaptoethanol, 10~ glycerol, 0.001~ bromophenol blue in 62.5 mM-Tris-HCl pH 6.8). Nuclei and cytoplasm were isolated from RK13 cells infected with CPV at an m.o.i, of 10 in the presence or absence of Ara C and were harvested 3 or 24 h post-infection (p.i.), or from mock-infected RK13 cells, using the procedures of Berkowitz et al. (1969) or Wing & Weissbach (1984) .
Twelve mice were immunized with CPV-infected BK cells cultured in the presence of Ara C. The screening of antibodies by the IF test was carried out with CPVinfected BK or RK13 cells (m.o.i. 5) cultured in the presence of Ara C for 12 h. Only two hybrid clones (designated as EA75 and EA86) found to stimulate antiviral antibodies were established from one mouse. Using the EA75 antibody, we examined the time course of antigen appearance by the IF test. RK13 cells were infected with CPV at an m.o.i, of 10 and cultured in the presence or absence of Ara C for 1, 2, 3, 5, 7, 9, 12 and 24 h. In CPV-infected cells in the presence of Ara C, fluorescence was first detectable within the nucleus 2 to 3 h after infection (Table 1 and Fig. 1 a) . The number of positive cells increased, and 24 h after infection approximately 90 ~ of the cells gave a positive reaction (Table 1) . However the fluorescence was almost entirely restricted to the nucleus in CPV-infected cells at any time (Table 1 and Fig. 1 c) . The antibody showed punctate or net-like fluorescence staining. On the other hand, in the absence of Ara C, about 6~o of the cells gave a positive reaction 2 h after infection (Table 1 ). The fluorescence was first detectable in the nucleus and migrated to the cytoplasm as the infection progressed (Fig. 1 b) . The intensity and number of specific fluorescence spots in the cytoplasm increased with time, and 7 to 24 h after infection approximately 90~ of the cells gave a positive reaction in the cytoplasm (Fig. l e) . The antibody showed punctate or granular fluorescence staining in the cytoplasm. No fluorescence was found at any time on the (Table 1) , which were directed against late proteins, i.e. the A-type inclusion protein, the nucleoprotein and haemagglutinin, respectively (Kitamoto et al., 1986 (Kitamoto et al., , 1987 .
We identified by Western blotting the polypeptide of the antigen reacting with EA75. For this analysis, RK 13 cells were mock-infected or infected with CPV at an m.o.i, of 10 in the presence or absence of Ara C for appropriate times (1, 2, 3, 5, 7, 9, 12, 16 and 24 h) and were then subjected to immunoblotting. One component only, with an Mr of 27K, was first detectable 2 h after infection. As shown in Fig. 2(a) , the 27K polypeptide was detected in infected cells in either the presence or absence of Ara C, and at early and late stages of infection, but not in mock-infected ceils in the presence .or absence of Ara C. Similar results were obtained with EA86, or with CPV-infected HeLa or L cells.
To obtain other viral polypeptides, RK13 cells were infected with VV (WR, Ikeda, Lister, IHD-J and IHD-W strains) or SFV at an m.o.i, of 10, and 16 h later the cells were harvested and subjected to immunoblotting. As shown in Fig. 2(b) , the 27K polypeptide was also detected in RK 13 cells infected with VV ( Fig. 2b ; lanes 5 to 10), but not in SFV- (Fig. 2b ; lane l l) or mockinfected cells. In addition we examined whether the antigen reacting with EA75 is a structural component of the cores or whether it is present within purified virions. Virions partially purified or fully purified as described above were used as antigens. No polypeptide was found in CPV or VV (Ikeda) virions purified from infected RK 13 cells ( Fig. 2b; lanes I and 3, respectively) , or in virions of the other strains of VV (data not shown). A weak polypeptide band was detected in partially purified virions of CPV (Fig. 2b, lane 2) ; this sample may still have contained cellular components. Similar results were obtained with the EA86 antibody in immunoblot analyses.
The EA75 MAb was used to probe extracts of cells infected with CPV at 3 or 24 h after infection in the presence or absence of Ara C. The 27K polypeptide was easily visible in the nuclear fraction of cells incubated with or without Ara C 3 h p.i., and in the cytoplasmic fraction in the absence of Ara C, but not in the cytoplasmic fraction in its presence. The polypeptide was easily detected in the nuclear fraction 24 h p.i. in the presence or absence of Ara C, and gave a strong signal in the cytoplasmic fraction in the absence of Ara C, but was Short communication (Table 2 ). The antigen was detected in CPV-infected cells treated with hydroxyurea which is an inhibitor of D N A replication. The specific fluorescence, like that in the Ara C experiments, was restricted almost completely to the nuclei of infected cells. Treatment with cordycepin (3'-deoxyadenosine), an inhibitor of R N A synthesis, caused the expression of the antigen to be inhibited, depending on the dose of reagent. The fluorescence was detected in both the cytoplasm and nucleus. Antigen was expressed also in infected cells treated with rifampicin, a specific inhibitor of prokaryotic R N A polymerase, and in those treated with at-amanitin which is an inhibitor of eukaryotic R N A polymerases II and III, and also with heparin and aurintricarboxylic acid (arminon) which are potent inhibitors of the viral R N A polymerase (Baroudy & Moss, 1980) . Actinomycin D which inhibits most R N A polymerases by binding to D N A had an effect on antigen expression which depended upon the dose of the reagent. The specific fluorescence was confined almost entirely to the cytoplasm in CPV-infected cells treated with these R N A polymerase inhibitors except for heparin; most of the fluorescence was observed within the nucleus. No antigen was found in any virus-infected cells treated with cycloheximide which inhibits protein synthesis, nor in cells infected with u.v.-irradiated CPV. Except for cordycepin, rifampicin and ~-amanitin, these reagents completely inhibited late protein synthesis; i.e. that of the A-type inclusion protein, the nucleoprotein and the haemagglutinin.
We have described two MAbs obtained from a mouse immunized with CPV-infected cells grown in the presence of Ara C, an inhibitor of viral D N A synthesis. The antigen reacting with EA75 or EA86 was readily detected in CPV-infected cells in the presence of Ara C but not in mock-infected cells. These results suggest that this antigen is a virus-specific early protein which is synthesized in the nucleus at an early stage and migrates to the cytoplasm during infection. Another possibility is that the antigen is synthesized in the cytoplasm and rapidly migrates to the nucleus, but migrates back into the cytoplasm at later times. However, no antigen was detected by the immunological techniques used in this study in the cytoplasm immediately after infection. Further studies on this particular aspect are in progress using other methods. Another early antigen, the early cell surface antigen(s), is known (Miyamoto & Kato, 1968; Ueda et al., 1969) , but our MAbs gave negative reactions with cell surface membranes in the IF and M I F tests. Also, the MAbs had no neutralizing activity. We reported earlier that a MAb (NT 1) reacting with the 28K to 27K polypeptide had neutralizing activity (Kitamoto et al., 1987) . Although the polypeptide reacting with EA75 seems to resemble that recognized by NT1, the Mr of the former was slightly lower than that of the latter. The IF staining pattern and the time course of the appearance of the antigen detected by EA75 were entirely different from those of NT1. As described previously (Dales & Pogo, 1981; Moss, 1974) , enzymes associated with the transcription of early genes are components of the cores and are packaged within the virions. It has also been shown that the large subunit of the host cell RNA polymerase II recruited from the nucleus to the cytoplasmic factories during infection is packaged into virions along with the other virus-encoded enzymes required for early gene transcription (Morrison & Moyer, 1986; Wilton & Dales, 1986 ). However we were unable to detect the presence of the antigen within purified virions, even when virion proteins were highly concentrated before immunoblotting to raise the reactivity and sensitivity. Our preliminary studies using an IF double staining test with EA75 and NP1 (probably detecting B-type inclusions or factories; Kitamoto et al., 1987) showed that these antigens were never found in the same area at any time. These results suggest that within the limits of sensitivity of the immunological techniques used in these studies, this antigen is unlikely to be a viral structural component or an enzyme packaged within the virions. Morrison et al. (1985) used MAbs directed against two subunits of rabbit poxvirus-associated DNA-dependent RNA polymerase, and reported that these subunits are synthesized late in the infectious cycle and are found only within the developing virosomes in the cytoplasm, neither subunit entering the nucleus. Also, Bloom et al. (1989) , using MAbs directed against core proteins of rabbit poxvirus, detected a lamin-like protein derived from the nucleus of the infected cell, which similarly to RNA polymerase II is recruited to the cytoplasm during infection.
The antigen reacting with our MAbs may not be a host cell RNA polymerase or a virus-associated RNA polymerase, because it was not affected by the inhibitors of host cell RNA polymerase and was not detected within purified virions. The expression of antigen was inhibited by cordycepin in a dose-dependent manner, and hence therefore the antigen may be associated with the process of RNA synthesis. With respect to this early antigen, the so-called switch-off phenomenon may not occur, because it was detected even at a late stage. In addition to the enzymes described above, a number of enzymes encoded by poxvirus genomes have been reported. However, as far as we have examined, this antigen does not correspond to any antigens reported previously. We are now carrying out further analyses on the characterization and biological activities of the antigen.
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